Everyone is aware that the record keeping, testing protocols did not meet the FDA criteria. But the physical proof cannot be ignored and the ADA doctors recommendations certainly would be worth the R & D gamble for pharma.
(5)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links